Please ensure Javascript is enabled for purposes of website accessibility

Dendrite Sold for 751M to CEGEDIM

Dendrite International in Bedminster entered into a definitive merger agreement with CEGEDIM in Paris to be acquired for $16 per share in cash. The deal values Dendrite at $751 million. CEGEDIM develops databasesDendrite International (Nasdaq: DRTE) in Bedminster entered into a definitive merger agreement with CEGEDIM in Paris to be acquired for $16 per share in cash. The deal values Dendrite at $751 million. CEGEDIM develops databases and software solutions. Dendrite provides software systems for sales, marketing, and compliance in pharmaceuticals. The merger is expected to create a company with estimated pro forma annual revenue of $1.1 billion, operating in more than 75 countries around the world. Dendrite’s board approved the sale of the company and urges shareholders to give their consent as well. Regulatory approval is also pending. Shares of Dendrite were up $2.73 to $15.52 in morning trading.

NJBIZ Business Events